LDL cholesterol burden in elderly patients with familial hypercholesterolemia: Insights from real-world data

Torunn Melnes1, Martin P Bogsrud2,3, Jacob J Christensen1

  • 1Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.

Insights

Familial hypercholesterolemia (FH) patients with coronary heart disease (CHD) had a higher LDL-C burden, especially before treatment. This highlights the critical need for early detection and intervention in FH to prevent cardiovascular events.

Area of Science:

  • Cardiology
  • Genetics
  • Metabolic Disorders

Background:

  • Familial hypercholesterolemia (FH) is a genetic disorder causing high LDL-C and premature coronary heart disease (CHD).
  • Cumulative LDL-C exposure (LDL-C burden) may be a better cardiovascular risk predictor than current LDL-C levels in FH.
  • Real-world data is crucial for understanding LDL-C burden in elderly FH patients.

Purpose of the Study:

  • To estimate LDL-C burden at various ages in elderly FH patients with and without CHD.
  • To assess the LDL-C burden at the time of CHD onset in FH patients.
  • To compare LDL-C burden between FH patients with and without CHD.

Main Methods:

  • Retrospective data collection from elderly FH patients (>60 years) at a Lipid Clinic.
  • Calculation of LDL-C burden (mM-years) using repeated LDL-C measurements and medication data.
  • Estimation of time-weighted average (TWA) LDL-C by dividing LDL-C burden by duration.

Main Results:

  • FH patients with CHD had a significantly higher LDL-C burden at ages 45, 50, and 60 compared to those without CHD.
  • Higher TWA LDL-C was observed before treatment initiation in the CHD group, but not during follow-up.
  • No significant sex differences in LDL-C burden were found, though women had higher TWA LDL-C during follow-up.

Conclusions:

  • Elderly FH patients with CHD exhibit a higher LDL-C burden, primarily due to elevated levels before treatment.
  • These findings underscore the importance of early diagnosis and aggressive lipid-lowering therapy in FH to mitigate cardiovascular risk.
  • The study emphasizes LDL-C burden as a key metric for assessing long-term cardiovascular risk in FH.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
100
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
458
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
566
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
465
Inflammation01:38

Inflammation

Overview
51.0K